quinagolide

Quinagolide
Systematic (IUPAC) name
	N,N-diethyl-N'-[(3S,4aS,10aR)-6-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-3-yl]sulfamide
Clinical data
AHFS/Drugs.com	International Drug Names
Legal status	℞ (Prescription only);
Routes of; administration	Oral
Identifiers
CAS Registry Number	87056-78-8
ATC code	G02CB04
PubChem	CID: 55645
ChemSpider	2343034
UNII	80Q9QWN15M
KEGG	D07217
ChEMBL	CHEMBL290962
Chemical data
Formula	C20H33N3O3S
Molecular mass	395.56 g/mol
	InChI InChI=1S/C20H33N3O3S/c1-4-10-22-14-17(21-27(25,26)23(5-2)6-3)11-16-12-18-15(13-19(16)22)8-7-9-20(18)24/h7-9,16-17,19,21,24H,4-6,10-14H2,1-3H3/t16-,17+,19-/m1/s1 ; Key:GDFGTRDCCWFXTG-ZIFCJYIRSA-N ;
(what is this?) (verify)

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/08/25 21:10:32」(JST)

Quinagolide (Norprolac) is a selective, D₂ receptor agonist that is used for the treatment of elevated levels of prolactin.^[1]

^ Antonella Di Sarno, Maria Luisa Landi, Paolo Marzullo, Carolina Di Somma, Rosario Pivonello, Gaetana Cerbone, Gaetano Lombardi, Annamaria Colao (July 2000). "The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas". Clinical Endocrinology 53 (1): 53–60. doi:10.1046/j.1365-2265.2000.01016.x. PMID 10931080.

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis.

Baumgarten M, Polanski L, Campbell B, Raine-Fenning N.SourceUniversity of Nottingham - NURTURE, Queen's Medical Centre , Nottingham , UK.
Human fertility (Cambridge, England).Hum Fertil (Camb).2013 Sep;16(3):168-74. doi: 10.3109/14647273.2013.833348.
Controlled ovarian stimulation is an integral part of assisted reproduction treatment. This can result in ovarian hyperstimulation syndrome (OHSS), which is associated with significant morbidity and potentially mortality. Recent approaches to ovarian stimulation have led to a reduction in the preval
PMID 24047196

Sowiński J, Sawicka N, Piątek K, Zybek A, Ruchała M.SourceDepartment of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poland.
Contemporary oncology (Poznań, Poland).Contemp Oncol (Pozn).2013;17(2):137-43. doi: 10.5114/wo.2013.34616. Epub 2013 Apr 29.
Nowadays physicians are under economic pressure; therefore therapeutic decisions based on safety, efficacy, and the effectiveness of the medication also require economic analysis. The aim of this review is to discuss data concerning the cost-effectiveness of drug therapy in patients with hormonally
PMID 23788980

Effect of prolactin-release inhibition on milk production and mammary gland involution at drying-off in cows.

Ollier S, Zhao X, Lacasse P.SourceDairy and Swine Research and Development Centre, Agriculture and Agri-Food Canada, Sherbrooke, Quebec, Canada J1M 0C8.
Journal of dairy science.J Dairy Sci.2013 Jan;96(1):335-43. doi: 10.3168/jds.2012-5955. Epub 2012 Nov 17.
The end of each lactation is a challenging period for high-yielding cows as they are often dried off while still producing significant quantities of milk and, consequently, are highly susceptible to new intramammary infections. Once involution is complete, the mammary gland becomes much more resista
PMID 23164222